Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

Bristol Myers Squibb has announced positive topline results from its phase 3 trial of Reblozyl (luspatercept-aamt), the first erythroid maturation agent for first-line treatment of patients with ...

UK biotech KaNDy Therapeutics is heading to phase 3 with its non-hormonal menopause drug, after a mid-stage trial showed it reduced hot flashes as well as improved quality of life, setting up a ...

The 2024/25 UEFA Champions League kicked off on 17 September and runs to the final in Munich on 31 May, with the best of the best doing battle once again to be crowned the elite side in Europe.

The company is also considering future expansion into forward or backward integration once it achieves the target of 3-4 million. If the company opts for forward integration, it plans to venture into ...